Statements (155)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:affects |
cancer development
|
gptkbp:associated_with |
gptkb:cervical_cancer
throat cancer anal cancer genital warts oropharyngeal cancer penile cancer |
gptkbp:can_detect |
molecular testing
|
gptkbp:cause |
gptkb:cervical_cancer
human papillomavirus infection |
gptkbp:clinical_trial |
ongoing
|
gptkbp:communication_system |
sexual contact
|
gptkbp:community_health |
gptkb:significant
yes education and awareness campaigns critical for reducing incidence |
gptkbp:community_impact |
public health initiatives
healthcare costs millions infected annually |
gptkbp:data_usage |
high
|
gptkbp:diagnosis |
biopsy
visual inspection HPV test Pap smear |
gptkbp:discovered_by |
gptkb:1980s
1970s the 1980s |
gptkbp:discovery |
gptkb:1980s
|
gptkbp:diseases |
gptkb:HIV
gptkb:head_and_neck_cancers throat cancer other STIs anal cancer vulvar cancer oropharyngeal cancer penile cancer |
gptkbp:epidemiology |
common worldwide
|
gptkbp:global_health_concern |
yes
|
gptkbp:has_a_focus_on |
clinical trials
public health campaigns vaccine development educational programs. |
gptkbp:has_lore |
only affects women
HPV is only a problem for older adults HPV is rare only sexually active individuals are at risk vaccination is unnecessary |
gptkbp:has_multiple_strains |
gptkb:HPV-16
gptkb:HPV-18 |
gptkbp:high-risk_types |
gptkb:HPV_16
gptkb:HPV_18 |
https://www.w3.org/2000/01/rdf-schema#label |
human papillomavirus
|
gptkbp:impact_on_men |
increased risk of anal cancer
|
gptkbp:included |
vaccination programs
|
gptkbp:incubation_period |
weeks to months
|
gptkbp:is_a_common_infection_in |
sexually active individuals
|
gptkbp:is_a_subject_of |
gptkb:media_coverage
educational initiatives government regulations scientific conferences international health discussions |
gptkbp:is_linked_to |
public awareness campaigns
vaccine hesitancy anogenital cancers |
gptkbp:is_preventable_through |
education about HPV
|
gptkbp:is_studied_for |
vaccine efficacy
|
gptkbp:is_studied_in |
oncology
|
gptkbp:is_vulnerable_to |
gptkb:Gardasil_9
gptkb:Cervarix gptkb:Gardasil high in preventing cervical cancer pre-teens and young adults |
gptkbp:issues |
healthcare providers
public health officials |
gptkbp:low-risk_types |
gptkb:HPV_11
gptkb:HPV_6 |
gptkbp:number_of_players |
most common STI in the US
over 80% of sexually active people will have it at some point |
gptkbp:occurs_in |
high among sexually active individuals
|
gptkbp:prevalence |
common sexually transmitted infection
most common sexually transmitted infection |
gptkbp:prevention |
vaccination
HPV vaccination safe sex practices |
gptkbp:provides_guidance_on |
WHO recommendations
CDC recommendations |
gptkbp:public_awareness |
important for prevention
|
gptkbp:research |
genetic studies
public health initiatives screening programs cancer prevention studies ongoing vaccine development |
gptkbp:research_focus |
gptkb:immunotherapy
new treatment options vaccine development cancer prevention vaccine safety screening technologies public health strategies understanding viral mechanisms |
gptkbp:risk_factor |
smoking
throat cancer weakened immune system oral cancer immunosuppression multiple sexual partners anal cancer other cancers early sexual activity |
gptkbp:risk_management |
young adults
immunocompromised individuals multiple sexual partners sexually active individuals based on sexual history |
gptkbp:risk_of_cancer |
persistent infection
|
gptkbp:scientific_classification |
Papillomaviridae
|
gptkbp:screenings |
HPV test
Pap smear |
gptkbp:seed_dispersal |
circular DNA
circular double-stranded DNA |
gptkbp:symptoms |
gptkb:Oncology
regular check-ups warts often asymptomatic dysplasia genital warts asymptomatic infection monitoring lesions persistent infection |
gptkbp:targets |
research funding
|
gptkbp:transmission |
sexual contact
|
gptkbp:treatment |
gptkb:immunotherapy
gptkb:surgery topical medications varies by individual laser therapy chemical treatment cryotherapy electrosurgery surgical removal of warts |
gptkbp:type |
DNA virus
high-risk HPV low-risk HPV |
gptkbp:type_of |
gptkb:virus
gptkb:HPV-16 gptkb:HPV-18 over 200 HPV-11 HPV-6 |
gptkbp:was_a_factor_in |
health disparities
cancer prevention strategies |
gptkbp:women's_team |
higher cervical cancer rates
|
gptkbp:bfsParent |
gptkb:HPV_vaccine
|
gptkbp:bfsLayer |
5
|